echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > A new form of vaccine - spherical nucleic acid vaccine, the first application of the new crown, the effect is amazing, has been used for cancer treatment

    A new form of vaccine - spherical nucleic acid vaccine, the first application of the new crown, the effect is amazing, has been used for cancer treatment

    • Last Update: 2022-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Against the backdrop of the COVID-19 pandemic raging around the world, amazing progress has been made in the field of vaccine research and development, and there are more and more different types of vaccines developed based on different principles


    The research team injected the uniquely designed spherical nucleic acid Covid-19 vaccine into mice subcutaneously to elicit an immune response to the SARS-CoV-2 spike protein, and then monitored antibody production for several weeks after injection


    Not only that, the research team also sent their vaccine to Argonne National Laboratory (ANL) in the United States for testing of new coronavirus in live animals.


    Professor Chad Mirkinsaid the study confirmed the importance of vaccine structure, which can have a profound impact on the efficacy of vaccines


    Against the backdrop of the COVID-19 pandemic raging around the world, amazing progress has been made in the field of vaccine research and development, and there are more and more different types of vaccines developed based on different principles


    Structural pattern diagram of the spherical nucleic acid new crown vaccine The research team injected this uniquely designed spherical nucleic acid new crown vaccine into mice subcutaneously to induce an immune response to the new coronavirus spike protein, and then monitored the production of antibodies within a few weeks after injection.


    The spherical nucleic acid new crown vaccine induces the production of higher titers of neutralizing antibodies.


    100% of the mice in the SNA vaccine protected experimental group The SNA vaccine protected 100 % of the mice in the experimental group.


     Professor Chad Mirkin Chad Mirkin Prevention of Emerging Infectious Diseases Prevention of Emerging Infectious Diseases The COVID-19 pandemic has caused hundreds of millions of infections and millions of deaths worldwide, and has had a profound impact on human society, which also highlights emerging infectious diseases terrifying .
    Therefore, how to effectively prevent emerging infectious diseases has become a difficult problem that human beings must face .
    Today, this research provides an answer to that question to some extent .
    Dr Max Distler, co-first author of the study  , said that while these experimental results were impressive, the team's goal was not to compete with existing Covid-19 vaccines, but to develop a new vaccine for the next infectious disease that requires a highly structured vaccine.
    be prepared .
    The spherical nucleic acid platform could even be used to treat complex diseases like AIDS .
    Professor Max Distler  Chad Mirkin  said that the modularity of the spherical nucleic acid vaccine research and development platform means that once a new infectious disease occurs, it may only be necessary to replace the antigen or adjuvant to quickly respond to future viruses .
    Therefore, spherical nucleic acid is not only a drug or a vaccine, but a research and development platform for various diseases and infectious diseases, which can help humans overcome intractable diseases such as cancer and emerging infectious diseases .
    Chad Mirkin 's paper link: https:// https://stm.
    sciencemag.
    org/content/13/584/eabb3945 Leave a comment here  

     


      

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.